Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results

GlobeNewswireOct 31 07:00 ET

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

BenzingaOct 30 15:12 ET

Perspective Therapeutics to Participate in Upcoming Investor Conferences in November

GlobeNewswireOct 29 07:00 ET

UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus

Seeking AlphaOct 24 15:32 ET

Wedbush Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Cuts Target Price to $20

Moomoo NewsOct 24 08:31 ET · Ratings

Perspective Therapeutics Initiated With a Buy at UBS

TipRanksOct 24 05:37 ET · Ratings